Richard Lemal

1.8k citations

81 papers · 512 indexed · h-index 11

Impact in

Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Transplantation top 10%

Papers in

Immunology 52
- T-cell and B-cell Immunology 46
- Immune Cell Function and Interaction 35
- Immunotherapy and Immune Responses 23
- Immunodeficiency and Autoimmune Disorders 6
Genetics 15
- Chronic Lymphocytic Leukemia Research 15

Co-authors: Olivier Tournilhac Paul Rouzaire Jacques‐Olivier Bay Aurélie Cabrespine Éric Hermet Corinne Bouteloup Romain Guièze Bruno Pereira
Journals: HLA (47 papers)Hematological Oncology (2 papers)Blood (2 papers)Clinical Nutrition (2 papers)Molecular Cancer Therapeutics (1 paper)
Partner nations: France United States Belgium

In The Last Decade

Richard Lemal

79 papers receiving 509 citations

Peers

Countries citing papers authored by Richard Lemal

Since Specialization

Citations

This map shows the geographic impact of Richard Lemal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Lemal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Lemal more than expected).

Fields of papers citing papers by Richard Lemal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Lemal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Lemal. The network helps show where Richard Lemal may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Richard Lemal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard Lemal Line = papers co-authored together Richard Lemal links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Characterization of the novel HLA‐DRB302:194* allele by sequencing‐based typing HLA ·Syed Sarwer Ali, Jonathan Visentin, Gwendaline Guidicelli, Richard Lemal, Paul Rouzaire	2024	2
2	Characterisation of the novel HLA‐DRB104:379N* allele by sequencing‐based typing HLA ·Syed Sarwer Ali, Mamy Ralazamahaleo, Gwendaline Guidicelli, Paul Rouzaire, Richard Lemal	2024	2
3	Characterisation of the novel HLA‐DRB401:182* allele by sequencing‐based typing HLA ·Syed Sarwer Ali, Marine Cargou, Antonio Marinelli Ibarreta, Richard Lemal, Paul Rouzaire	2024	2
4	Characterisation of the novel HLA‐DQA105:112* allele by sequencing‐based typing HLA ·Syed Sarwer Ali, Jonathan Visentin, Antonio Marinelli Ibarreta, Richard Lemal, Paul Rouzaire	2024	2
5	Characterization of the novel HLA‐DQB102:01:01:21Q* allele by sequencing‐based typing HLA ·Syed Sarwer Ali, Gwendaline Guidicelli, Antonio Marinelli Ibarreta, Paul Rouzaire, Richard Lemal	2024	1
6	Characterization of the novel HLA‐DRB111:324* allele by sequencing‐based typing HLA ·Syed Sarwer Ali, Marine Cargou, Gwendaline Guidicelli, Paul Rouzaire, Richard Lemal	2023	2
7	Adoptive T Cell Therapy in Solid Tumors: State-of-the Art, Current Challenges, and Upcoming Improvements Molecular Cancer Therapeutics ·P. Brown, F. Cornu, Richard Lemal, Paul Rouzaire	2023	9
8	Impact of Calcineurin Inhibitor-Based Immunosuppression Maintenance During the Dialysis Period After Kidney Transplant Failure on the Next Kidney Graft Outcome: A Retrospective Multicenter Study With Propensity Score Analysis Transplant International ·M.K.C. Jager, Valentin Mayet, Maria Hélida Guedes Logrado, Lionel Couzi, Denise Bowles, Antoine Thierry, Laure Écotière, Dominique Bertrand, Charlotte Laurent, Richard Lemal, Clarisse Grèze, Liu Ai, Anne-Élisabeth Heng, 孝明柿並, Cyril Garrouste	2023	2
9	Characterization of the novel HLA‐C16:98:02* allele by sequencing‐based typing HLA ·Syed Sarwer Ali, Jonathan Visentin, И.Л. Березин, Richard Lemal, Paul Rouzaire	2023	2
10	Characterization of the novel HLA‐DPA101:03:51* allele by sequencing‐based typing HLA ·Syed Sarwer Ali, Antonio Marinelli Ibarreta, Mamy Ralazamahaleo, Paul Rouzaire, Richard Lemal	2023	2
11	Relation between auditory difficulties and bortezomib-induced peripheral neuropathy in multiple myeloma: a single-center cross-sectional study European Archives of Oto-Rhino-Laryngology ·Fabrice Giraudet, Marie Selvy, Nicolas Kerckhove, Bruno Pereira, B Abdullah, Daniel P. Nguyen, Jérôme Busserolles, Aurélie Cabrespine, Carine Chaleteix, Martin Soubrier, Jacques‐Olivier Bay, Richard Lemal, David Balayssac	2022	3
12	Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study Frontiers in Pharmacology ·Marie Selvy, Nicolas Kerckhove, Bruno Pereira, B Abdullah, Daniel P. Nguyen, Jérôme Busserolles, Fabrice Giraudet, Aurélie Cabrespine, Carine Chaleteix, Martin Soubrier, Jacques‐Olivier Bay, Richard Lemal, David Balayssac	2021	34
13	Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS The Journal of Allergy and Clinical Immunology In Practice ·Richard Lemal, Guillemette Fouquet, Louis Terriou, K. Nagatsu, C. Bulaï Livideanu, Laurent Frenzel, Stéphane Barète, Danielle Canioni, Ludovic Lhermitte, Julien Rossignol, Michel Arock, Patrice Dubreuil, Olivier Lortholary, Olivier Hermine	2019	39
14	Les CAR-T cells sont là ! Bulletin du Cancer ·Rutger De Wit, P. Brown, Jacques‐Olivier Bay, Richard Lemal	2018	2
15	Pomalidomide dans les myélomes multiples Bulletin du Cancer ·P. Brown, Richard Lemal, Carine Chaleteix	2017	2
16	Utilisation des inhibiteurs de PD-1 dans les hémopathies lymphoïdes Bulletin du Cancer ·石渡利奈, Emmy Isbring, Jacques‐Olivier Bay, Richard Lemal	2016	1
17	Could enteral nutrition improve the outcome of patients with haematological malignancies undergoing allogeneic haematopoietic stem cell transplantation? A study protocol for a randomized controlled trial (the NEPHA study) Trials ·Richard Lemal, Aurélie Cabrespine, Bruno Pereira, Kate Galambos, M. Mammen, Éric Hermet, Jacques‐Olivier Bay, Corinne Bouteloup	2015	21
18	Enteral versus parenteral nutritional support in allogeneic haematopoietic stem-cell transplantation Clinical Nutrition ·Romain Guièze, Richard Lemal, Aurélie Cabrespine, Éric Hermet, Olivier Tournilhac, Kate Galambos, Jacques‐Olivier Bay, Corinne Bouteloup	2013	66
19	Avancées thérapeutiques majeures et nouvelles perspectives en onco-hématologie Bulletin du Cancer ·Jacques‐Olivier Bay, Romain Guièze, M. Mammen, Richard Lemal, Aliénor Xhaard, Sébastien Bailly, Cécile Moluçon‐Chabrot, Éric Hermet, J. Biau, Pierre Verrelle, Régis Peffault de Latour, Olivier Tournilhac	2013	8
20	Les inhibiteurs des histone-désacétylases en onco-hématologie Bulletin du Cancer ·Richard Lemal, M. Mammen, Cécile Moluçon‐Chabrot, Jacques‐Olivier Bay, Romain Guièze	2011	3

About Richard Lemal

Richard Lemal is a scholar working on Immunology, Genetics, Transplantation, Hematology and Immunology and Allergy, having authored 81 papers that have together received 512 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (46 papers), Immune Cell Function and Interaction (35 papers), Immunotherapy and Immune Responses (23 papers), Chronic Lymphocytic Leukemia Research (15 papers), vaccines and immunoinformatics approaches (12 papers), Lymphoma Diagnosis and Treatment (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). The work is most often cited by research in Genetics (115 citations), Transplantation (27 citations), Hematology (108 citations), Immunology (152 citations) and Pathology and Forensic Medicine (97 citations). Richard Lemal has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Olivier Tournilhac, Paul Rouzaire, Jacques‐Olivier Bay, Aurélie Cabrespine, Éric Hermet, Corinne Bouteloup, Romain Guièze, Bruno Pereira, Marine Cargou and Jonathan Visentin. Their work appears in journals such as HLA, Hematological Oncology, Blood, Clinical Nutrition and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact